Latest Breaking News On - Unanimous approval during independently - Page 1 : comparemela.com

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the successful completion of a trial program featuring the.

Michael polyviou todd kehrliSteve foosheeSource biolase incExchange commissionBiolase incPrnewswire biolase incReceives overwhelmingly positive dentist feedbackUnanimous approval during independentlyPerformance satisfactionWider adoptionPlus all tissueAdvanced laserRussell morrowChief dental officerWaterlase expressPrivate litigation reform act